Literature DB >> 2827118

Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1).

S M Harrison1, K L Gearing, S Y Kim, A J Kingsman, S M Kingsman.   

Abstract

A 1.0 kb region of the BPV-1 genome (the long control region, LCR), contains controls for transcription and the origin of replication. Transcription directed by the LCR is activated by the viral encoded E2 protein. To define the essential cis acting elements that are required to control transcription we have constructed a series of deletions throughout the LCR. We have identified three important domains in the LCR, two of which respond to E2. We have analysed the ability of small subcloned regions of the E2 responsive domains to act as enhancers in a heterologous assay system. This has led to the identification of five independent E2 responsive elements. We have shown that a fragment of only 38 base pairs is sufficient to respond to activation by E2. We also present evidence to suggest two types of E2 responsiveness that result in strong or weak activation. Strong response is correlated with the presence of the sequence 5'-ACCG/TNNNC/TCGGTGC-3' whereas weak response is correlated with the presence of a related sequence 5'-ACC(N)6GGT-3'. The contribution of these multiple elements to viral transcription is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827118      PMCID: PMC339943          DOI: 10.1093/nar/15.24.10267

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.

Authors:  B A Spalholz; Y C Yang; P M Howley
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene.

Authors:  J T Schiller; W C Vass; K H Vousden; D R Lowy
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids.

Authors:  J M Roberts; H Weintraub
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Fine structure genetic analysis of a beta-globin promoter.

Authors:  R M Myers; K Tilly; T Maniatis
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

5.  Messenger RNAs from the transforming region of bovine papilloma virus type I.

Authors:  A Stenlund; J Zabielski; H Ahola; J Moreno-Lopez; U Pettersson
Journal:  J Mol Biol       Date:  1985-04-20       Impact factor: 5.469

6.  Bovine papillomavirus contains multiple transforming genes.

Authors:  Y C Yang; H Okayama; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Identification of a second transforming region in bovine papillomavirus DNA.

Authors:  J T Schiller; W C Vass; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Dissociation of transforming and trans-activation functions for bovine papillomavirus type 1.

Authors:  Y C Yang; B A Spalholz; M S Rabson; P M Howley
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

9.  High efficiency DNA-mediated transformation of primate cells.

Authors:  C Gorman; R Padmanabhan; B H Howard
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

10.  Identification of the human papilloma virus-1a E4 gene products.

Authors:  J Doorbar; D Campbell; R J Grand; P H Gallimore
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  16 in total

1.  Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.

Authors:  P Monini; S R Grossman; B Pepinsky; E J Androphy; L A Laimins
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor.

Authors:  S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity.

Authors:  D J Riese; J Settleman; K Neary; D DiMaio
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription.

Authors:  M Sowden; S Harrison; R Ashfield; A J Kingsman; S M Kingsman
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

5.  Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

Authors:  M T Chin; T R Broker; L T Chow
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells.

Authors:  P F Lambert; N L Hubbert; P M Howley; J T Schiller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements.

Authors:  C M Sanders; N J Maitland
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

8.  Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter.

Authors:  B A Spalholz; S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells.

Authors:  P Szymanski; A Stenlund
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Synthesis of a gene for the HIV transactivator protein TAT by a novel single stranded approach involving in vivo gap repair.

Authors:  S E Adams; I D Johnson; M Braddock; A J Kingsman; S M Kingsman; R M Edwards
Journal:  Nucleic Acids Res       Date:  1988-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.